切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2019, Vol. 08 ›› Issue (02) : 165 -169. doi: 10.3877/cma.j.issn.2095-3224.2019.02.012

所属专题: 文献

综述

结直肠子宫内膜异位症恶变的研究进展
李宁宁1, 赵林1,()   
  1. 1. 100730 北京,中国医学科学院北京协和医院肿瘤内科
  • 收稿日期:2018-04-19 出版日期:2019-04-25
  • 通信作者: 赵林

Research progress of malignant transformation of intestinal endometriosis

Ningning Li1, Lin Zhao1,()   

  1. 1. Department of Medical Oncology, PUMC Hospital, CAMS and PUMC, Beijing 100032, China
  • Received:2018-04-19 Published:2019-04-25
  • Corresponding author: Lin Zhao
  • About author:
    Corresponding author: Zhao Lin, Email:
引用本文:

李宁宁, 赵林. 结直肠子宫内膜异位症恶变的研究进展[J]. 中华结直肠疾病电子杂志, 2019, 08(02): 165-169.

Ningning Li, Lin Zhao. Research progress of malignant transformation of intestinal endometriosis[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2019, 08(02): 165-169.

子宫内膜异位症在育龄期妇女中是一种相对常见的病变,但肠道的子宫内膜异位组织恶变比较罕见。其病因未明,目前用以解释其起源的理论较多。尽管目前针对这种少见疾病无标准治疗方法,但是根治性手术结合术后辅助治疗的模式可作为一种治疗选择。

Endometriosis is a relatively common condition in women of reproductive age. But malignant transformation of intestinal endometriosis is a very rare event. The etiopathogenesis is unknown. There are several theories reported to explain the origin of endometriosis-associated malignancies(EAM). Although there is no standard therapy due to the rare occurrence of such cases, a surgery followed by adjuvant therapy appears to be the treatment of choice.

[1]
Kobayashi S, Sasaki M, Goto T, et al. Endometrioid adenocarcinoma arising from endometriosis of the rectosigmoid [J]. Dig Endos, 2010, 22(1):59-63.
[2]
Katsikogiannis N, Tsaroucha A, Dimakis K, et al. Rectal endometriosis causing colonic obstruction and concurrent endometriosis of the appendix: a case report [J]. J Med Case Rep, 2011, 5:320.
[3]
Pisanu A, Deplano D, Angioni S, et al. Rectal perforation from endometriosis in pregnancy: case report and literature review [J]. World J Gastroenterol, 2010, 16(5):648-651.
[4]
LaGrenade A, Silverberg SG. Ovarian tumors associated with atypical endometriosis [J]. Hum Pathol, 1988, 19(9):1080-1084.
[5]
Ogawa S, Kaku T, Amada S, et al. Ovarian endometriosis associated with ovarian carcinoma: a cliniclpathological and immunohistochemical study [J]. Gynecol Oncol, 2000, 77(2):298-304.
[6]
Czernobilsky B, Morris WJ. A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes [J]. Obstet Gynecol, 1979, 53(3):318-323.
[7]
Fukunaga M, Nomura K, Ishikawa E, et al. Ovarian atypical endometriosis: its close association with malignant epithelial tumours [J]. Histopathology, 1997, 30(3):249-255.
[8]
Worley MJ, Welch WR, Berkowitzwitz RS, et al. Endometriosis-associated ovarian cancer: a review of pathogenesis [J]. Int J Mol Sci, 2013, 14(3):5367-5379.
[9]
Zanetta GM, Webb MJ, Li H, et al. Hyperestrogenenism: a relevant risk factor for the development of cancer from endometriosis [J]. Gynecol Oncol, 2000, 79(1):18-22.
[10]
Kobayashi H, Yamada Y, Kanayama S, et al. The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary [J]. Int J Gynecol Cancer, 2009, 19(3):471-479.
[11]
Keita M, AinMelk Y, Pelmus M, et al. Endometrioid ovarian cancer and endometriotic cells exhibit the same alteration in the expression of interleukin-1 receptor Ⅱ: to a link between endometriosis and endometrioid ovarian cancer [J]. J Obstet Gynaecol Res, 2011, 37(2):99-107.
[12]
Keita M, Bessette P, Pelmus M, et al. Expression of interleukin-1(IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes [J]. J Ovarian Res, 2010,3:3.
[13]
Yamaguchi K, Mandai M, Toyokuni S, et al. Contents of endometriotic cysts, especiallythe high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress [J]. Clin Cancer Res, 2008, 14(1):32-40.
[14]
Matsumoto T,Yamazaki M,Takahashi H,et al.Distinct betacaterin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinoma [J]. Am J Clin Patrol, 2015, 144(3):452-463.
[15]
Gadducci A, Lanfredini N, Tana R.Novel insights on the malignant transformation of endomatriosis into ovarian carcinoma [J]. Gynecol Endocrinol, 2014, 30(9):612-617.
[16]
Anglesio MS, Bashashati A, Wang YK, et al. Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden [J]. J Pathol, 2015, 236(2):201-209.
[17]
Nezhat F, Datta MS, Hanson V, et al. The relationship of endometriosis and ovarian malignancy: a review [J]. Fertil Steril, 2008, 90(5):1559-1570.
[18]
Munksgaard PS, Blaakaer J. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations [J]. Gynecol Oncol, 2012, 124(1):164-169.
[19]
Lai CR, Hsu CY, Chen YJ, et al. Ovarian cancers arising from endometriosis: a microenvironmental biomarker study including ER, HNF1ss, p53, PTEN, BAF250a, and COX-2 [J]. J Chin Med Assoc, 2013, 76(11):629-634.
[20]
McConechy MK, Ding J, Senz J, et al. Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles [J]. Mod Pathol, 2014, 27(1):128-134.
[21]
Kobayashi S, Sasaki M, Goto T, et al. Endometrioid adenocarcinoma arising from endometriosis of the rectosigmoid [J]. Dig Endos, 2010, 22(1):59-63.
[22]
Marchena-Gomez J, Conde-Martel A, Hemmersbach-Miller M, et al. Metachronic malignant transformation of small bowel and rectal endo-metriosis in the same patient [J]. World J Surg Oncol, 2006, 4:93.
[23]
Debus G, Schuhmacher I. Endometrial adenocarcinoma arising during estrogenic treatment 17 years after total abdominal hysterectomy and bilateral salpingo-oophorectomy: A case report [J]. Acta Obstet Gynecol Scand, 2001, 80(6):589-590.
[24]
Ulrich U, Rhiem K, Kaminski M, et al. Paramatrial and rectovaginal adenocarcinoma arising from endometriosis [J]. Int J Gynecol Cancer, 2005, 15(6):1206-1209.
[25]
Remorgida V, Ferrero S, Fulcheri E, et al. Bowel endometriosis:presentation,diagnosis,and treatment [J]. Obstet Gynecol Furv, 2007, 62(7):461-470.
[26]
Cottreau CM, Ness RB, Modugno F, et al. Endometriosis and its treatment with Danazol or Lupron in relation to ovarian cancer [J]. Clinical Cancer Research, 2003, 9(14):5142-5144.
[27]
Kobayashi H, Sumimoto K, Kitanaka T, et al. Ovarian endometrioma risks factors of ovarian cancer development [J]. Eur J Obstet Gynecol Reprod Biol, 2008, 138(2):187-193.
[28]
Erzen M, Raker S, Klancar B, et al. Endometriosis-associated ovarian carcinoma(EAOC): An entity distinct from other ovarian carcinomas as suggested by a nested case-control study [J]. Gynecol Oncol, 2001, 83(1):100-108.
[29]
Campbell IG, Thomas EJ. Endometriosis: candidate genes [J]. Human Reproduction Update, 2001, 7(1):15-20.
[30]
Birnbaum LS, Cummings AM. Dioxins and endometriosis: a plausible hypothesis [J]. Environ Health Perspect, 2002, 110(1):15-21.
[31]
Sampson JA. Endometrial carcinoma of the ovary arising in endometrial tissue in that organ [J]. Arch Surg, 1925, 9(1):111-114.
[32]
Pearce CL, Templeman C, Rossing MA, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies [J]. Lancet Oncol, 2012, 13(4):385-394.
[33]
Slavin RE, Krum R, Dinh TV. Endometriosis-associated intestinal tumors: a clinical and pathological study of 6 cases with a review of the literature [J]. Hum Pathol, 2000, 31(4):456-463.
[34]
Jones KD, Owen E, Berresford A, et al. Endometrial adenocarcinoma arising from endometriosis of the rectosigmoid colon [J]. Gynecol Oncol, 2002, 86(2):220-222.
[35]
Werling RW, Yaziji H, Bacchi CE, et al.CDX2, a highly sensitive and specific marker of adenocarcinoma as of intestinal origin: an immunohistochemocal survey of 476 primary and metastatic carcinomas [J]. Am J Surg Pathol, 2003, 27(3):303-310.
[36]
Miura K, Ishida K, Fujibuchi W, et al. Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database [J]. Surg Today, 2012, 42(6):515-525.
[37]
Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases [J]. Mod Pathol, 2000, 13(9):962-972.
[38]
Poleev A, Fickenscher H, Mundlos S, et al. PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms′ tumors [J]. Development, 1992, 116(3):611-623.
[39]
Schaner ME, Ross DT, Ciaravino G, et al. Gene expression patterns in ovarian carcinomas [J]. Mol Biol Cell, 2003, 14(11):4376-4386.
[40]
Modesitt SC, Tortolero-Luna G, Robinson JB, et al. Ovarian and extraovarian endometriosis-associated cancer [J]. Obstet Gynecol, 2002, 100(4):788-795.
[41]
Heaps JM, Nieberg RK, Berek JS.Malignant neoplasms arising in endometriosis [J]. Obstet Gynecol, 1990, 75(6):1023-1028.
[42]
Fishman A, Demirel D, Laucirica R, et al.Malignant tumors arising in endometriosis: clinical-pathological study and flow cytometry analysis [J].Obstet Gynecol, 1996, 70(1):69-74.
[43]
Irvin W, Pelkey T, Rice L, et al. Andersen.Endometrial stromal sarcoma of the vulva arising in extraovarian endometriosis: a case report and literature review [J]. Gynecol Oncol, 1998, 71(2):313-316.
[44]
Davis M, Rauh-Hain JA, Andrade C, et al. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary [J]. Gynecol Oncol, 2014, 132(3):760-766.
[45]
Ulruch U, Richter O, Wardelmann E, et al. Endometriosis and malignoma [J]. Zentralbl Gynakol, 2003, 125(7-8):239-242.
[46]
Slomovtz B, Soslow R, Chang R, et al.Serous adenocarcinoma of the inguinal region arising from endometriosis followed by a successful pregnancy [J]. Gynecol Oncol, 2002, 87(1):152-154.
[47]
Judson P, Temple A, Fowler W, et al. Vaginal adenosarcoma arising from endometriosis [J]. Gynecol Oncol, 2000, 76(1):123-125.
[48]
Sutton G, Blessing JA, Park R, et al. Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncologic Group [J]. Obstet Gynecol, 1996, 87(5Pt1):747-750.
[49]
Erzen M, Rakar S, Klancnik B, et al. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study [J]. Gynecol Oncol, 2001, 83(1):100-108.
[50]
Petersen VC, Underwood JCE, Wells M, et al. Primary endometrioid adenocarcinoma of the large intestine arising in colorectal endometriosis [J]. Histopathology, 2002, 40(2):171-176.
[1] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[2] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[3] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[4] 付佳, 肖海敏, 武曦, 冯涛, 师帅. 年龄校正查尔森合并症指数对腹腔镜结直肠癌围手术期并发症的预测价值[J]. 中华普通外科学文献(电子版), 2023, 17(05): 336-341.
[5] 薛永婷, 高峰, 王雅楠, 屈莲平. 溶瘤病毒治疗在结直肠癌中的应用[J]. 中华普通外科学文献(电子版), 2023, 17(05): 380-384.
[6] 武慧铭, 郭仁凯, 李辉宇. 机器人辅助下经自然腔道取标本手术治疗结直肠癌安全性和有效性的Meta分析[J]. 中华普通外科学文献(电子版), 2023, 17(05): 395-400.
[7] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[8] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[9] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[10] 常剑, 邱峰, 毛郁琪. 摄食抑制因子-1与腹腔镜结直肠癌根治术后肝转移的关系分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 502-505.
[11] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[12] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[13] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[14] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[15] 王丁然, 迟洪滨. 自身免疫甲状腺炎对子宫内膜异位症患者胚胎移植结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(06): 682-688.
阅读次数
全文


摘要